Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 59651-842

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 59651-842). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))

Package Label-principal Display Panel (50 mg (60 Tablet Bottle))
Label for Diclofenac Sodium Delayed-Release Tablets USP 50 mg by Aurobindo Pharma Limited. The label shows 60 tablets per container. It includes directions for storage, handling, and a pharmacist advisory. Distributed by Aurobindo Pharma USA Inc., made in India, with NDC 59651-842-60 and barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (75 mg (60 Tablet Bottle))

Package Label-principal Display Panel (75 mg (60 Tablet Bottle))
Label for Diclofenac Sodium Delayed-Release Tablets, USP 75 mg by Aurobindo Pharma Limited. The label indicates 60 tablets, includes dosage and storage instructions, pharmacist dispensing note, distributor address in East Windsor, NJ, and a sample image of a round pink tablet marked 'D75'. It also includes NDC 59651-843-60 and barcode.*
FDA Label Image

Chemical Structure (Diclofenac Str)

Chemical Structure (Diclofenac Str)
Chemical structure diagram of diclofenac sodium illustrating its molecular composition with two benzene rings, two chlorine atoms, an amine group, and a sodium carboxylate group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.